Linical Co.,Ltd.
| Market Cap | 6.3B |
| P/E Ratio | - |
| P/B Ratio | 1.12 |
| EPS | -23.87 |
| Dividend Yield | - |
| D/E Ratio | 1.31 |
| Current Ratio | 1.56 |
| Market Segment | Standard |
| Accounting | Japan GAAP |
| Currency | JPY |
Business Overview
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | IT & SERVICES, OTHERS |
| Market Segment | Standard |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2025 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | Linical Co.,Ltd. |
| Ticker | 2183 |
| Exchange | TSE |
| Sector | Services |
| Industry | IT & SERVICES, OTHERS |
| Market Segment | Standard |
| Accounting | Japan GAAP |
| Fiscal Year | 2025 |
| Currency | JPY |
| Market Cap | 6.3B |
| Revenue | 10.4B |
| Net Income | -539.1M |
| P/E Ratio | - |
| EPS | -23.87 |
| Net Margin | -5.2% |
| ROE | -7.4% |
| Dividend Yield | - |
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.